What is the benefit of late administration of thrombolytic therapy ?
ISIS-2 (Lancet 1988; ii:349-60) showed benefit for up to 24 hours (after onset of symptoms) with thrombolysis, but more recent studies - LATE (Late Assessment of Thrombolytic Therapy) and EMRAS (Estudio Multicentrico Esteptoquinasa Republicas de America del Sur) - have shown no benefit for treatment given beyond 12 hours.
Lexo edhe:
ISIS-2 (Lancet 1988; ii:349-60) showed benefit for up to 24 hours (after onset of symptoms) with thrombolysis, but more recent studies - LATE (Late Assessment of Thrombolytic Therapy) and EMRAS (Estudio Multicentrico Esteptoquinasa Republicas de America del Sur) - have shown no benefit for treatment given beyond 12 hours.
loading...
Lexo edhe: